Article Details
Retrieved on: 2018-03-17 12:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Finally, <b>Acadian Asset Management</b> LLC grew its stake in shares of Summit Therapeutics by 192.8% during the 4th quarter. <b>Acadian Asset Management</b> LLC now owns 144,083 shares of the company's stock worth $1,595,000 after purchasing an additional 94,876 shares during the period. 29.03% of ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here